Matthew P. Goetz, MD

Oncologist
Mayo Clinic
Rochester, MN
Authored Items
Questions About Treating Patients Using a CDK4/6 Inhibitor
Matthew P. Goetz, MD
Conference Correspondent  in Breast Cancer, Video, SABCS
The Use of Chemotherapy in the Metastatic Setting
Matthew P. Goetz, MD
Conference Correspondent  in Breast Cancer, Video, SABCS
The Mechanism of Action of CDK4/6 Inhibitors
Matthew P. Goetz, MD
Conference Correspondent  in Breast Cancer, Video, SABCS
CDK4/6 Inhibitors in HER2+ Metastatic Breast Cancer
Matthew P. Goetz, MD
Conference Correspondent  in Breast Cancer, Video, SABCS
Abemaciclib, Ribociclib, or Palbociclib for HR+ Metastatic Breast Cancer?
Matthew P. Goetz, MD
Conference Correspondent  in Breast Cancer, Video, SABCS
Last modified: December 5, 2017